comparemela.com

Latest Breaking News On - Fatima suleman - Page 6 : comparemela.com

Cost of cancer: Health experts champion availability, a

At a webinar around the theme “Inequities to cancer medicines in South Africa”, Salome Meyer from non-profit organisation Cancer Alliance said on Tuesday that Covid-19 had served to further prove the inequities of the South African health system and that “Availability” of medicines needed to be coupled with “Affordability”, which would then translate into “Access” to medicines for everyone in need. Quoting former president Nelson Mandela, Meyer said “health cannot be a question of income; it is a basic human right”. The Cancer Alliance produced a report in 2017 titled Patent Barriers of Cancer Medicines that showed patents blocked the availability of more accessible generic medicines. Meyer said the report stated that only seven of the 21 registered cancer medicines available in the private sector were available in the public health sector.

Accessibility to cancer medicines under discussion

Accessibility to cancer medicines under discussion By Zainul Dawood Share DURBAN - DISCUSSIONS are taking place at a global level with the World Health Organisation (WHO), pharmaceutical industries and other stakeholders as to what constitutes a fair price for cancer medicines. Professor Fatima Suleman at UKZN stated this during a webinar hosted by University of KwaZulu-Natal (UKZN) and World Health Organization Collaboration Centre (WHO CC) for Pharmaceutical Policy and Evidence Based Practice on Tuesday. Suleman highlighted the imbalance of medicine access and possible solutions to ensure equitable access. “The cost of the whole cancer care pipeline and hidden costs of chemotherapy and transport are not factored into the cancer care. Medicines play a big role, even those on medical schemes. It can force people to go into bankruptcy,” she said.

How do you price a life-saving vaccine during a pandemi

While South Africa shared its Covid-19 vaccine price publicly, the prices paid by the European Union (EU) are only publicly known due to an accidental tweet of the EU’s price list by Belgium’s Budget State Secretary, Eva De Bleeker.  Pharmaceutical companies have provided a range of justifications for charging different countries different prices for the same vaccines. These justifications include the income-level and size of procuring countries, the provision of public investment towards vaccine development and manufacturing scale-up by countries, the timing of orders and delivery, and the willingness of buyers to maintain price secrecy.  While these justifications may sound rational and even fair at face value, they often do not hold up against evidence of what countries are actually paying.

ANALYSIS | How do you price a life-saving vaccine during a pandemic?

ANALYSIS | How do you price a life-saving vaccine during a pandemic?
news24.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news24.com Daily Mail and Mail on Sunday newspapers.

Cross-Country Collaborations to Improve Access to Medicines and Vaccines in the WHO European Region

"[T]he importance of information exchange was highlighted by all collaborations." Access to safe, effective, high-quality, and affordable essential medicines is one of the major challenges for health systems in achieving universal health coverage, to which countries have committed as part of the 2030 Agenda for Sustainable Development (target 3.8).

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.